Baclofen and acamprosate based therapy of alzheimer's disease in patients having lost responsiveness to acetylcholinesterase inhibitor therapy

• 收藏
• 分享

专利权人:

Pharnext

发明人:

BRUREAU, Anthony,CHOLET, Nathalie,COHEN, Daniel,HAJJ, Rodolphe,NABIROCHKIN, Serguei

申请号：

AU2019211135

公开号：

AU2019211135A1

申请日:

2019.01.28

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present invention relates to combinations and methods based on Baclofen and Acamprosate for the treatment of Alzheimer's disease or Alzheimer's related disorders in patients who do not respond to an inhibitor of acetylcholinesterase, typically in patients treated with an inhibitor of acetylcholinesterase and who have lost responsiveness to said 5 inhibitor of acetylcholinesterase.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/